BDR Pharmaceuticals International Private Limited — Tamoxifen Exporter Profile
Indian Pharmaceutical Exporter · #4 for Tamoxifen · $830.4K export value · DGFT Verified
BDR Pharmaceuticals International Private Limited is the #4 Indian exporter of Tamoxifen with $830.4K in export value and 48 verified shipments. BDR Pharmaceuticals International Private Limited holds a 5.6% market share in Tamoxifen exports across 2 countries. The company exports 12 pharmaceutical products worth $4.4M across 3 therapeutic categories.
BDR Pharmaceuticals International Private Limited — Tamoxifen Export Profile: Buyers & Destinations
Where Does BDR Pharmaceuticals International Private Limited Export Tamoxifen?
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED KINGDOM | $506.2K | 21 | 68.3% |
| THAILAND | $234.8K | 27 | 31.7% |
BDR Pharmaceuticals International Private Limited exports Tamoxifen to 2 countries. The largest destination is UNITED KINGDOM accounting for 68.3% of BDR Pharmaceuticals International Private Limited's Tamoxifen shipments. These destinations reflect BDR Pharmaceuticals International Private Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Tamoxifen from BDR Pharmaceuticals International Private Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| TILLOMED LABORATORIES LIMITED | UNITED KINGDOM | $398.0K | 14 |
| PIPHLPT | THAILAND | $129.4K | 14 |
| TILLOMED LABORATORIES LTD | UNITED KINGDOM | $69.4K | 6 |
| PIPHLTPA | THAILAND | $51.7K | 10 |
| TILLABLTD | UNITED KINGDOM | $38.8K | 1 |
| PIPHLPT PINYO PHARMACY LTD | THAILAND | $27.5K | 2 |
| PIPHLPT PINYO PHARMACY LIMITED | THAILAND | $26.3K | 1 |
BDR Pharmaceuticals International Private Limited supplies Tamoxifen to 7 buyers globally. The largest buyer is TILLOMED LABORATORIES LIMITED (UNITED KINGDOM), followed by PIPHLPT (THAILAND) and TILLOMED LABORATORIES LTD (UNITED KINGDOM). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Tamoxifen Export Value and How Much Does BDR Pharmaceuticals International Private Limited Contribute?
India exported $11.0M worth of Tamoxifen through 3,139 shipments from 220 suppliers to 104 countries, serving 377 buyers globally. BDR Pharmaceuticals International Private Limited contributes $830.4K to this total, accounting for 5.6% of India's Tamoxifen exports. BDR Pharmaceuticals International Private Limited ships Tamoxifen to 2 countries through 7 buyers.
What Is the Average Shipment Value for BDR Pharmaceuticals International Private Limited's Tamoxifen Exports?
BDR Pharmaceuticals International Private Limited's average Tamoxifen shipment value is $17.3K per consignment, based on 48 shipments totaling $830.4K. The largest destination is UNITED KINGDOM (68.3% of BDR Pharmaceuticals International Private Limited's Tamoxifen exports).
How Does BDR Pharmaceuticals International Private Limited Compare to Other Indian Tamoxifen Exporters?
BDR Pharmaceuticals International Private Limited ranks #4 among 220 Indian Tamoxifen exporters with a 5.6% market share. The top 3 exporters are EUGIA PHARMA SPECIALITIES LIMITED ($6.7M), GRANULES INDIA LIMITED ($1.3M), BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED ($830.4K). BDR Pharmaceuticals International Private Limited processed 48 shipments to 2 destination countries.
What Tamoxifen Formulations Does BDR Pharmaceuticals International Private Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| TAMOXIFEN TABLETS BP 20MG | $245.8K | 7 |
| TAMOXIFEN 20 MG TABLETS | $154.8K | 6 |
| TAMOXIFEN 20MG TABS (BD-FUTURE)TAMOXIFENTABLETS BP 20MG (39200 PACK X10=392000TABS) (TAX INVMH1160000415 DT07.12.202 | $50.0K | 1 |
| PHARMACEUTICAL FINISH FORMULATION TAMOXIFEN TABLETS BP 20MG 32417 PACK OF 30TABLETS | $41.5K | 1 |
| TAMOXIFEN TABLETS BP 20MG (EACH UNCOATED | $38.7K | 1 |
| TAMOXIFEN 20MG TABLETS | $36.7K | 1 |
| TEMOXIFINE 20MG TABSBD-FUTURETAMOXIFEN TABLETS BP 20MG41410 PACK X1X10=414100 TABSTAX INVMH1160000262 DT13.09.2 | $27.5K | 2 |
| TEMOXIFINE 20MG TABSBD-FUTURETAMOXIFEN TABLETS BP 20MG78800 PACK X1X10=788000 TABSTAX INVMH1160000368 DT10.11.2 | $26.3K | 1 |
| . TAMOXIFEN 10 MG TABLETS | $13.9K | 4 |
| TAMOXIFEN 20 MG TABS (BD-FUTURE)(TAMOXIFEN TABLETS BP 20MG) )(39170 PACK X 10=391,700 TABS)(TAX INV#MH2511600 | $13.6K | 1 |
BDR Pharmaceuticals International Private Limited exports 23 distinct Tamoxifen formulations including tablets, capsules, syrups, and combination drugs. The top formulation is TAMOXIFEN TABLETS BP 20MG with 7 shipments worth $245.8K.
Regulatory Requirements: Exporting Tamoxifen to Key Markets
What BDR Pharmaceuticals International Private Limited must comply with to export Tamoxifen to its top destination countries
United Kingdom — MHRA
Approval Process
Post-Brexit UK Marketing Authorisation via national procedure. Separate from EU approval since January 2021.
Timeline: 12–15 months
GMP & Export Requirements
UK GMP compliance; MHRA inspection of manufacturing site
Manufacturer Import Authorisation (MIA) held by UK importer; Qualified Person (QP) batch release
Note: Post-Brexit: EU GMP certificates no longer automatically valid in UK. Separate MHRA recognition required.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does BDR Pharmaceuticals International Private Limited Compare to Nearest Tamoxifen Exporters?
Exporters ranked immediately above and below #4 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | EUGIA PHARMA SPECIALITIES LIMITED | $6.7M | 182 | 5 | $36.6K |
| 3 | GRANULES INDIA LIMITED | $1.3M | 25 | 2 | $50.0K |
| 4 | BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED ★ | $830.4K | 48 | 2 | $17.3K |
| 5 | KHANDELWAL LABORATORIES PRIVATE LIMITED | $742.7K | 32 | 7 | $23.2K |
| 6 | WOCKHARDT LIMITED | $409.8K | 9 | 1 | $45.5K |
BDR Pharmaceuticals International Private Limited ranks #4 among 220 Indian Tamoxifen exporters. Average shipment value of $17.3K compared to the market average of $50.0K. The closest competitors by value are EUGIA PHARMA SPECIALITIES LIMITED and GRANULES INDIA LIMITED.
Which Indian Ports Ship Tamoxifen Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 776 | 24.7% |
| DELHI AIR CARGO ACC (INDEL4) | 638 | 20.3% |
| SAHAR AIR | 541 | 17.2% |
| DELHI AIR | 301 | 9.6% |
| Bombay Air | 177 | 5.6% |
| Delhi Air | 91 | 2.9% |
| HYDERABAD AIR | 80 | 2.5% |
| Bombay Air Cargo | 57 | 1.8% |
What Other Advanced Oncology Products Does BDR Pharmaceuticals International Private Limited Export?
BDR Pharmaceuticals International Private Limited also exports these advanced oncology products. Each links to the detailed product page.
About BDR Pharmaceuticals International Private Limited
BDR Pharmaceuticals International Private Limited exports 12 products worth $4.4M. Beyond Tamoxifen, top products include Everolimus, Lapatinib, Capecitabine, Thalidomide, Amphotericin. View the complete BDR Pharmaceuticals International Private Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Tamoxifen — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Tamoxifen shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: BDR Pharmaceuticals International Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 48 individual customs records matching BDR Pharmaceuticals International Private Limited exporting Tamoxifen, covering 23 formulations to 2 countries via 7 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 104+ countries, 377+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Tamoxifen Export Data from BDR Pharmaceuticals International Private Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for BDR Pharmaceuticals International Private Limited's Tamoxifen exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
BDR Pharmaceuticals International Private Limited
Full Company Profile →
12 products · $4.4M total trade · 3 categories
Tamoxifen Stats
Company Overview
Top Products by BDR Pharmaceuticals International Private Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for BDR Pharmaceuticals International Private Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Tamoxifen. For current shipment-level data, contact TransData Nexus.